Highlight selection of radiochemistry and radiopharmacy developments by editorial board

IF 4.4 Q1 CHEMISTRY, INORGANIC & NUCLEAR

EJNMMI Radiopharmacy and Chemistry Pub Date : 2024-09-16 DOI:10.1186/s41181-024-00296-6

Peter JH. Scott, Ivan Penuelas, Ana Rey, Silvio Aime, Pillai M.R. Ambikalmajan, Ines Farinha Antunes, Frederik Cleeren, Zhaofei Liu, Beverley Ellis, Maryke Kahts, Fany Pricile Ekoume, Ivis F. Chaple, Emerson Bernardes, Martin Behe, Ya-Yao Huang, Renata Mikolajczak, Shozo Furumoto, Amal Elrefaei, Klaus Kopka

{"title":"Highlight selection of radiochemistry and radiopharmacy developments by editorial board","authors":"Peter JH. Scott, Ivan Penuelas, Ana Rey, Silvio Aime, Pillai M.R. Ambikalmajan, Ines Farinha Antunes, Frederik Cleeren, Zhaofei Liu, Beverley Ellis, Maryke Kahts, Fany Pricile Ekoume, Ivis F. Chaple, Emerson Bernardes, Martin Behe, Ya-Yao Huang, Renata Mikolajczak, Shozo Furumoto, Amal Elrefaei, Klaus Kopka","doi":"10.1186/s41181-024-00296-6","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.</p><h3>Main body</h3><p>This selection of highlights provides commentary on 19 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.</p><h3>Conclusion</h3><p>Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.</p></div>","PeriodicalId":534,"journal":{"name":"EJNMMI Radiopharmacy and Chemistry","volume":"9 1","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ejnmmipharmchem.springeropen.com/counter/pdf/10.1186/s41181-024-00296-6","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJNMMI Radiopharmacy and Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1186/s41181-024-00296-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, INORGANIC & NUCLEAR","Score":null,"Total":0}

引用次数: 0

Abstract

Background

The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.

Main body

This selection of highlights provides commentary on 19 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.

Conclusion

Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.

查看原文本刊更多论文

编辑委员会对放射化学和放射药学发展的重点选择

背景EJNMMI《放射药剂学与化学》编辑委员会每半年发布一期重点评论，向读者介绍放射药剂开发领域的最新趋势。正文本期重点评论精选了19个不同的主题，这些主题由每位共同撰稿的编辑委员会成员选定，涉及从新型放射化学到新型放射药剂的首次人体应用等多个方面。热点话题涵盖了 EJNMMI 放射药剂学和化学的整个范围，从多个方面展示了该研究领域的进展。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

EJNMMI Radiopharmacy and Chemistry Multiple-

CiteScore

7.20

自引率

8.70%

发文量

审稿时长

5 weeks